KLOW

A next-generation injectable peptide blend combining BPC-157, TB-500, GHK-Cu, and KPV, four of the most widely studied compounds in injury recovery, inflammation control, and tissue regeneration. Each peptide targets a specific biological repair pathway, and together they offer a comprehensive, multi-system healing solution for advanced research models.

This synergistic blend is designed for researchers looking to study complex injury protocols, multi-tissue regeneration, and systemic inflammatory modulation, without having to combine and dose each peptide individually.

🧑🏼‍🔬HOW DOES IT WORK?

🧬BPC-157 supports angiogenesis, collagen synthesis, and gut barrier repair, allowing to heal just about any injury.

🧬TB-500, a synthetic fragment of thymosin beta-4, exhibits systemic healing potential, particularly in tendons, ligaments, and cardiac tissue, with anti-fibrotic properties.

🧬GHK-Cu has been studied for its influence on wound healing, skin rejuvenation, hair growth and tissue repair.

🧬KPV is a powerful anti-inflammatory tripeptide showing promise in models of IBD, eczema, and immune overactivation.

🌟KLOW allows researchers to evaluate the effects of all these peptides at once.

❤️‍🩹WHAT CAN IT HEAL?

The components of KLOW BLEND have been studied for potential healing applications including:

- Tendon and ligament injuries

- Muscle tears and strains

- Joint inflammation and overuse syndromes

- Skin wounds, scarring, and aging-related degradation

- Hair follicle stimulation and scalp regeneration

- Gastrointestinal lining damage and ulcers

- Post-surgical recovery

- Cardiac & brain repair

While early findings are promising, data on humans is still limited.

👩🏽‍⚕️👨🏻‍⚕️WHO IS IT BEING DEVELOPED FOR?

🌟KLOW BLEND is intended exclusively for qualified researchers and laboratories conducting studies on:

Multi-tissue injury recovery

Inflammation-driven tissue damage

Post-operative or post-trauma regeneration

Aesthetic recovery models (skin, hair, collagen, barrier integrity)

Gut and epithelial healing protocols

Its all-in-one format makes it especially useful for broad recovery models, multi-pathway peptide synergy, and reducing injection volume in animal studies.

 ❗️we highly recommend research be done with independent compounds. It is imperative to understand compounds are extremely fragile and unstable. 

There are base and acidic compounds. They do not mix well. Degradation is inevitable when blending components together. GHK-cu becomes nearly a total loss. BPC-157 will lose 10-15% upon reconstitution, and up to a 40% loss of potency in as little as a couple hours. KPV & TB-500 are proven to maintain at higher levels of integrity but they are in fact affected. 

All compounds are available separately and remain the recommended protocol for all research purposes.